Author

Kristoffer G. Skaarup

Observed name: Kristoffer G Skaarup

Institutions: University of Copenhagen, Herlev Hospital, Copenhagen University Hospital, Gentofte Hospital

Observed institutions: University of Copenhagen, Herlev Hospital, Copenhagen University Hospital, Gentofte Hospital

OpenAlex ID: A5133570113

A pragmatic randomized trial to evaluate the vaccine effectiveness of bivalent RSV prefusion F vaccine for preventing RSV hospitalizations in adults (DAN-RSV): Trial design update

2026 · Mats C. Højbjerg Lassen, Sine H. Christensen, et al. · American Heart Journal · 6

Durability of RSV Prefusion F Vaccine Protection across Two RSV Seasons

2026 · Mats C. H. Lassen, Niklas Dyrby Johansen, et al. · NEJM Evidence · 1

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2

2026 · Caroline Espersen, Niklas D Johansen, et al. · The Lancet Healthy Longevity · 1

Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trial

2026 · Lisa Steen Duus, Mats C H Lassen, et al. · European Journal of Preventive Cardiology · 1

Bivalent RSV Prefusion F Protein-based Vaccine Effectiveness in Persons With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial

2026 · Manan Pareek, Mats C. Højbjerg Lassen, et al.

Bivalent RSV Prefusion F Protein-based Vaccine Effectiveness in Persons With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial

2026 · Manan Pareek, Mats C. Højbjerg Lassen, et al.

Works count: 6

Citation count: 9

H-index: 1

I10-index: